Correction to: From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials
- PMID: 40698986
- PMCID: PMC12284879
- DOI: 10.1093/ijnp/pyaf051
Correction to: From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials
Erratum for
-
From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials.Int J Neuropsychopharmacol. 2025 Apr 11;28(4):pyaf015. doi: 10.1093/ijnp/pyaf015. Int J Neuropsychopharmacol. 2025. PMID: 40056428 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
